Gal-3 was also shown to play a role in nephrogenesis as it is upregulated with fetal kidney maturation [28, 29] and in diabetic nephropathy, as it functions acts an advanced glycation end products (AGE) receptor in vivo thereby providing protection against AGE-dependent tissue injury [30]. Here, LGALS3 is linked to diabetic kidney disease.